Smith+Nephew gets FDA clearance for new hip surgery system

Orthopedic

Smith+Nephew earned 501(k) clearance from the FDA for its Catalystem Primary Hip System.

The system aims to tackle the changing needs and demands of primary hip surgery, including the expanding role of ambulatory surgery centers in hip procedures, according to a July 16 news release. 

The Catalystem system is designed to be effective for direct anterior approach, which is becoming more common.

The direct anterior approach is a less invasive surgery, leading to improved range of motion and faster recovery times, the release said.

Subscribe to the following topics: smith+nephew501(k) clearancefdacatalystem primary hip systemprimary hip surgery

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like